Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Cardiology›Kansas City Cardiomyopathy Questionnaire (KCCQ)
Process / pipelinecardiomyopathy and heart failure quality of life

Kansas City Cardiomyopathy Questionnaire (KCCQ)

Also known as: KCCQ

The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item, multidimensional self-report measure that evaluates heart failure-related symptoms, functional limitations, and quality of life in patients with cardiomyopathy and heart failure of all severities. Developed by Spertus and colleagues in 2000, the KCCQ provides six disease-specific domains and a clinically summary score, making it ideal for comprehensive, domain-focused assessment in both clinical practice and research.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Kansas City Cardiomyopathy Questionnaire
Duke Activity Status Ind…Minnesota Living with He…New York Heart Associati…Seattle Angina Questionn…Heart Failure Somatic Aw…

When to use it

The KCCQ is suitable for all heart failure patients (HFrEF, HFmrEF, HFpEF) across care settings. Specific indications include: (1) comprehensive baseline QoL assessment capturing multiple domains for holistic care planning, (2) domain-specific monitoring to track targeted interventions (diuretic uptitration for Symptom Burden, exercise for Physical Limitation, psychotherapy for Emotional Health), (3) clinical trials as a FDA-recommended primary outcome for HF drug and device studies, (4) research requiring multidimensional QoL data, and (5) shared decision-making conversations where domain-level feedback motivates patients. The KCCQ is less practical for high-volume clinics with time constraints due to longer administration time compared to MLHFQ.

Strengths & limitations

Strengths
  • Multidimensional: six distinct domains permit identification of specific areas of burden and targeted intervention, rather than relying on a single aggregate score.
  • FDA-endorsed: the Clinical Summary Score is recommended by FDA and ESC as a co-primary outcome in HF pivotal trials, ensuring regulatory and scientific credibility.
  • Responsive across HF phenotypes: KCCQ performs well in HFrEF, HFmrEF, HFpEF, and acute decompensated HF, with maintained psychometric properties across ejection fraction spectrum.
  • Captures emotional and social domains: explicit measurement of emotional health and social limitation goes beyond physical symptom assessment, addressing patient-centered outcomes.
  • Optional Overall Summary Score: users can report a single total score for brevity or all six domains for detail, adapting to clinical workflow.
Limitations
  • Longer administration time: 8–12 minutes is substantially longer than MLHFQ (5–8 min), potentially limiting use in busy clinic schedules.
  • Multiple scores require interpretation expertise: clinicians must understand all six domains and their clinical implications; a single global score is simpler to communicate.
  • Moderate correlation with objective HF markers: like all QoL measures, KCCQ correlates modestly with EF and BNP; perceived limitation does not track physiology perfectly.
  • Potential for response-shift bias: adaptation to chronic illness may dampen apparent improvement over long follow-up periods.
  • Domain overlap: some items contribute to multiple domains (e.g., fatigue to both Symptom Burden and Physical Limitation), creating modest interdomain correlation that may reduce discriminative ability.

Frequently asked

What is the difference between KCCQ and MLHFQ?

MLHFQ is a single-score instrument (21 items, 0–105) measuring overall HF burden; KCCQ is multidimensional (23 items, six domains 0–100 each). MLHFQ is faster (5–8 min) and simpler, making it ideal for routine clinic monitoring. KCCQ provides domain-specific detail (symptom vs. emotional vs. social burden), making it better for comprehensive assessment and research. Both are valid; choice depends on whether single-score tracking (MLHFQ) or multidimensional profiling (KCCQ) aligns with clinical workflow.

What clinically important difference (CID) should I use for KCCQ?

For the Clinical Summary Score (primary outcome), a 5-point improvement is considered clinically meaningful in HF trials. For individual domains, CID ranges 3–7 depending on domain (Symptom Burden CID ≈ 5, Emotional Health CID ≈ 3–4). In practice, any ≥5-point change warrants clinical attention to assess concordance with symptom history and objective markers (BNP, EF).

Is there a shortened KCCQ for busy clinics?

Yes, the KCCQ-12 is a validated 12-item version derived from the full KCCQ, yielding a single Physical Limitation/Symptom Burden score (0–100) in 3–4 minutes. KCCQ-12 is ideal for high-volume clinics and frequent monitoring. The full KCCQ remains preferable for baseline assessment or when domain-specific detail is needed for research.

Can I use KCCQ in acute decompensated heart failure?

Yes, KCCQ is responsive in acute HF settings and has been validated during hospitalization and at discharge. However, it is most useful for serial measurement to track recovery trajectory; baseline KCCQ at admission may be confounded by acute distress. Follow-up KCCQ at 2–4 weeks post-discharge captures post-hospitalization QoL recovery and guides intensification decisions.

How do I interpret a low Emotional Health domain?

Low Emotional Health (0–24) indicates significant depression, anxiety, or worry about heart condition. This warrants: (1) screening for major depression (PHQ-9), (2) assessment for medication-induced mood disorder (e.g., beta-blockers, diuretic-induced hypokalemia), (3) disease-education intervention to address knowledge deficits, and (4) mental health referral if depression is confirmed. Emotional Health often improves with psychotherapy or antidepressants independent of HF severity.

Sources

  1. Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health-related quality of life measure for heart failure. Journal of the American College of Cardiology, 35(5), 1245–1253. DOI: 10.1016/S0735-1097(00)00531-3 ↗

How to cite this page

ScholarGate. (2026, June 3). Kansas City Cardiomyopathy Questionnaire (KCCQ). ScholarGate. https://scholargate.app/en/cardiology/kansas-city-cardiomyopathy

Related methods

Duke Activity Status IndexMinnesota Living with Heart Failure QuestionnaireNew York Heart Association Functional ClassificationSeattle Angina Questionnaire

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Duke Activity Status IndexCardiology↔ compare
  • Minnesota Living with Heart Failure QuestionnaireCardiology↔ compare
  • New York Heart Association Functional ClassificationCardiology↔ compare
  • Seattle Angina QuestionnaireCardiology↔ compare
Compare side by side →

Referenced by

Duke Activity Status IndexHeart Failure Somatic Awareness ScaleMinnesota Living with Heart Failure QuestionnaireNew York Heart Association Functional ClassificationSeattle Angina Questionnaire

Similar methods

Minnesota Living with Heart Failure QuestionnaireCHQHeart Failure Somatic Awareness ScaleNew York Heart Association Functional ClassificationSeattle Angina QuestionnaireDuke Activity Status IndexPedsQL Cardiac ModuleKDQOL

Related reference concepts

Heart Failure and CardiomyopathyHeart Failure ManagementHeart FailureSystolic Heart Failure (Reduced Ejection Fraction)Heart Failure PathophysiologyCardiac Rehabilitation and Exercise

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Kansas City Cardiomyopathy Questionnaire (Kansas City Cardiomyopathy Questionnaire (KCCQ)). Retrieved 2026-07-21 from https://scholargate.app/en/cardiology/kansas-city-cardiomyopathy · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
John A. Spertus
Subfamily
cardiomyopathy and heart failure quality of life
Year
2000
Type
Self-report questionnaire
Related methods
Duke Activity Status IndexMinnesota Living with Heart Failure QuestionnaireNew York Heart Association Functional ClassificationSeattle Angina Questionnaire
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account